• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由RNA聚合酶II驱动的微小RNA支架表达的不依赖Dicer的短发夹RNA实现高效敲低且无乘客链活性

Efficient Knockdown and Lack of Passenger Strand Activity by Dicer-Independent shRNAs Expressed from Pol II-Driven MicroRNA Scaffolds.

作者信息

Kaadt Erik, Alsing Sidsel, Cecchi Claudia R, Damgaard Christian Kroun, Corydon Thomas J, Aagaard Lars

机构信息

Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark.

Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus C, Denmark.

出版信息

Mol Ther Nucleic Acids. 2019 Mar 1;14:318-328. doi: 10.1016/j.omtn.2018.11.013. Epub 2018 Dec 1.

DOI:10.1016/j.omtn.2018.11.013
PMID:30654192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6348697/
Abstract

The expression of short hairpin RNAs (shRNAs) may result in unwanted activity from the co-processed passenger strand. Recent studies have shown that shortening the stem of conventional shRNAs abolishes passenger strand release. These Dicer-independent shRNAs, expressed from RNA polymerase III (Pol III) promoters, rely on Ago2 processing in resemblance to miR-451. Using strand-specific reporters, we tested two designs, and our results support the loss of passenger strand activity. We demonstrate that artificial primary microRNA (pri-miRNA) transcripts, expressed from Pol II promoters, can potently silence a gene of choice. Among six different scaffolds tested, miR-324 and miR-451 were readily re-targeted to direct efficient knockdown from either a CMV or a U1 snRNA promoter. Importantly, the miR-shRNAs have no passenger strand activity and remain active in Dicer-knockout cells. Our vectors are straightforward to design, as we replace the pre-miR-324 or -451 sequences with a Dicer-independent shRNA mimicking miR-451 with unpaired A-C nucleotides at the base. The use of Pol II promoters allows for controlled expression, while the inclusion of pri-miRNA sequences likely requires Drosha processing and, as such, mimics microRNA biogenesis. Since this improved and tunable system bypasses the requirement for Dicer activity and abolishes passenger strand activity completely, it will likely prove favorable in both research and therapeutic applications in terms of versatility and enhanced safety.

摘要

短发夹RNA(shRNA)的表达可能会因共加工的过客链而产生不必要的活性。最近的研究表明,缩短传统shRNA的茎干可消除过客链的释放。这些由RNA聚合酶III(Pol III)启动子表达的不依赖Dicer的shRNA,类似于miR-451,依赖Ago2进行加工。使用链特异性报告基因,我们测试了两种设计,结果支持过客链活性的丧失。我们证明,由Pol II启动子表达的人工初级微小RNA(pri-miRNA)转录本可以有效地沉默目标基因。在测试的六种不同支架中,miR-324和miR-451很容易被重新靶向,以从CMV或U1 snRNA启动子直接进行有效的敲低。重要的是,miR-shRNA没有过客链活性,并且在Dicer基因敲除细胞中仍保持活性。我们的载体设计简单,因为我们用在碱基处具有不成对A-C核苷酸的模仿miR-451的不依赖Dicer的shRNA替换了pre-miR-324或-451序列。使用Pol II启动子可实现可控表达,而包含pri-miRNA序列可能需要Drosha加工,因此模仿了微小RNA的生物合成过程。由于这种改进的、可调节的系统绕过了对Dicer活性的需求,并完全消除了过客链活性,因此在通用性和增强安全性方面,它可能在研究和治疗应用中都具有优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae76/6348697/d91049c0f4e4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae76/6348697/fa3852d30527/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae76/6348697/9e81becfea34/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae76/6348697/842d07fa5c8b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae76/6348697/d91049c0f4e4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae76/6348697/fa3852d30527/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae76/6348697/9e81becfea34/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae76/6348697/842d07fa5c8b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae76/6348697/d91049c0f4e4/gr4.jpg

相似文献

1
Efficient Knockdown and Lack of Passenger Strand Activity by Dicer-Independent shRNAs Expressed from Pol II-Driven MicroRNA Scaffolds.由RNA聚合酶II驱动的微小RNA支架表达的不依赖Dicer的短发夹RNA实现高效敲低且无乘客链活性
Mol Ther Nucleic Acids. 2019 Mar 1;14:318-328. doi: 10.1016/j.omtn.2018.11.013. Epub 2018 Dec 1.
2
-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy.靶向性微小RNA-短发夹RNA在视网膜基因治疗中兼具疗效、特异性和安全性。
Mol Ther Nucleic Acids. 2022 Feb 28;28:58-76. doi: 10.1016/j.omtn.2022.02.019. eCollection 2022 Jun 14.
3
Towards Antiviral shRNAs Based on the AgoshRNA Design.基于AgoshRNA设计的抗病毒短发夹RNA研究
PLoS One. 2015 Jun 18;10(6):e0128618. doi: 10.1371/journal.pone.0128618. eCollection 2015.
4
Mechanistic insights on the Dicer-independent AGO2-mediated processing of AgoshRNAs.关于Dicer非依赖性AGO2介导的AgoshRNAs加工的机制见解。
RNA Biol. 2015;12(1):92-100. doi: 10.1080/15476286.2015.1017204.
5
Silencing of HIV-1 by AgoshRNA molecules.AgoshRNA分子使HIV-1沉默。
Gene Ther. 2017 Aug;24(8):453-461. doi: 10.1038/gt.2017.44. Epub 2017 May 29.
6
miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction.用于谱系特异性敲低BCL11A和诱导胎儿血红蛋白的miRNA嵌入短发夹RNA
Mol Ther. 2015 Sep;23(9):1465-74. doi: 10.1038/mt.2015.113. Epub 2015 Jun 17.
7
Influence of a 3' Terminal Ribozyme on AgoshRNA Biogenesis and Activity.3' 末端核酶对AgoshRNA生物合成及活性的影响
Mol Ther Nucleic Acids. 2019 Jun 7;16:452-462. doi: 10.1016/j.omtn.2019.04.001. Epub 2019 Apr 8.
8
Optimization and comparison of knockdown efficacy between polymerase II expressed shRNA and artificial miRNA targeting luciferase and Apolipoprotein B100.靶向荧光素酶和载脂蛋白 B100 的聚合酶 II 表达 shRNA 与人工 miRNA 的敲低效率优化与比较。
BMC Biotechnol. 2012 Jul 24;12:42. doi: 10.1186/1472-6750-12-42.
9
Boosting AgoshRNA activity by optimized 5'-terminal nucleotide selection.通过优化 5'-末端核苷酸选择来提高 AgoshRNA 的活性。
RNA Biol. 2019 Jul;16(7):890-898. doi: 10.1080/15476286.2019.1599259. Epub 2019 Apr 16.
10
Toward optimization of AgoshRNA molecules that use a non-canonical RNAi pathway: variations in the top and bottom base pairs.朝着利用非经典RNAi途径的AgoshRNA分子的优化方向:顶部和底部碱基对的变化。
RNA Biol. 2015;12(4):447-56. doi: 10.1080/15476286.2015.1022024.

引用本文的文献

1
Molecular Therapeutics for Diabetic Kidney Disease: An Update.糖尿病肾病的分子治疗:最新进展。
Int J Mol Sci. 2024 Sep 19;25(18):10051. doi: 10.3390/ijms251810051.
2
Subretinal AAV delivery of RNAi-therapeutics targeting reduces choroidal neovascularization in a large animal model.在大型动物模型中,通过视网膜下注射腺相关病毒(AAV)递送靶向RNA干扰疗法可减少脉络膜新生血管形成。
Mol Ther Methods Clin Dev. 2024 Mar 22;32(2):101242. doi: 10.1016/j.omtm.2024.101242. eCollection 2024 Jun 13.
3
25 years of maturation: A systematic review of RNAi in the clinic.

本文引用的文献

1
Differences in silencing of mismatched targets by sliced versus diced siRNAs.切割与切块 siRNA 对错配靶标沉默的差异。
Nucleic Acids Res. 2018 Jul 27;46(13):6806-6822. doi: 10.1093/nar/gky287.
2
Dicer-independent processing of small RNA duplexes: mechanistic insights and applications.小RNA双链体的Dicer非依赖性加工:机制洞察与应用
Nucleic Acids Res. 2017 Oct 13;45(18):10369-10379. doi: 10.1093/nar/gkx779.
3
Analysis of AgoshRNA maturation and loading into Ago2.AgoshRNA的成熟及加载到Ago2中的分析
25年的发展历程:对临床RNA干扰技术的系统综述
Mol Ther Nucleic Acids. 2023 Jul 18;33:469-482. doi: 10.1016/j.omtn.2023.07.018. eCollection 2023 Sep 12.
4
Terminal bridging of siRNA duplex at the ribose 2' position controls strand bias and target sequence preference.核糖2'位置处小干扰RNA双链体的末端桥接控制链偏好性和靶序列偏好性。
Mol Ther Nucleic Acids. 2023 Apr 19;32:468-477. doi: 10.1016/j.omtn.2023.04.013. eCollection 2023 Jun 13.
5
A Circular RNA Expressed from the FAT3 Locus Regulates Neural Development.环状 RNA 来源于 FAT3 基因座,调控神经发育。
Mol Neurobiol. 2023 Jun;60(6):3239-3260. doi: 10.1007/s12035-023-03253-7. Epub 2023 Feb 25.
6
-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy.靶向性微小RNA-短发夹RNA在视网膜基因治疗中兼具疗效、特异性和安全性。
Mol Ther Nucleic Acids. 2022 Feb 28;28:58-76. doi: 10.1016/j.omtn.2022.02.019. eCollection 2022 Jun 14.
7
miRNA-Mediated Knockdown of ATXN3 Alleviates Molecular Disease Hallmarks in a Mouse Model for Spinocerebellar Ataxia Type 3.miRNA 介导的 ATXN3 敲低可减轻脊髓小脑共济失调 3 型小鼠模型中的分子疾病特征
Nucleic Acid Ther. 2022 Jun;32(3):194-205. doi: 10.1089/nat.2021.0020. Epub 2021 Dec 7.
8
nucleates a transcription inhibitory complex to balance neuronal differentiation.核转录抑制复合物以平衡神经元分化。
Elife. 2020 Nov 11;9:e58478. doi: 10.7554/eLife.58478.
9
Short Hairpin RNAs for Strand-Specific Small Interfering RNA Production.用于链特异性小干扰RNA产生的短发夹RNA
Front Bioeng Biotechnol. 2020 Aug 7;8:940. doi: 10.3389/fbioe.2020.00940. eCollection 2020.
10
Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update.基因治疗干预新生血管性眼病:最新进展。
Mol Ther. 2020 Oct 7;28(10):2120-2138. doi: 10.1016/j.ymthe.2020.06.029. Epub 2020 Jun 30.
PLoS One. 2017 Aug 15;12(8):e0183269. doi: 10.1371/journal.pone.0183269. eCollection 2017.
4
The influence of the 5΄-terminal nucleotide on AgoshRNA activity and biogenesis: importance of the polymerase III transcription initiation site.5′端核苷酸对AgoshRNA活性及生物合成的影响:聚合酶III转录起始位点的重要性
Nucleic Acids Res. 2017 Apr 20;45(7):4036-4050. doi: 10.1093/nar/gkw1203.
5
Design of Effective Primary MicroRNA Mimics With Different Basal Stem Conformations.具有不同基础茎构象的有效初级微小RNA模拟物的设计
Mol Ther Nucleic Acids. 2016 Jan 12;5(1):e278. doi: 10.1038/mtna.2015.53.
6
Ribozyme-enhanced single-stranded Ago2-processed interfering RNA triggers efficient gene silencing with fewer off-target effects.核酶增强的单链AGO2加工干扰RNA触发高效基因沉默且脱靶效应更少。
Nat Commun. 2015 Oct 12;6:8430. doi: 10.1038/ncomms9430.
7
The Menu of Features that Define Primary MicroRNAs and Enable De Novo Design of MicroRNA Genes.定义初级微小RNA并实现微小RNA基因从头设计的特征菜单。
Mol Cell. 2015 Oct 1;60(1):131-45. doi: 10.1016/j.molcel.2015.08.015. Epub 2015 Sep 24.
8
Deep Sequence Analysis of AgoshRNA Processing Reveals 3' A Addition and Trimming.AgoshRNA加工的深度序列分析揭示了3'端腺苷酸添加和修剪
Mol Ther Nucleic Acids. 2015 Jul 14;4(7):e247. doi: 10.1038/mtna.2015.19.
9
Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.通过共递送RNA诱饵减轻载体编码短发夹RNA的脱靶效应。
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4007-16. doi: 10.1073/pnas.1510476112. Epub 2015 Jul 13.
10
Functional Anatomy of the Human Microprocessor.人类微处理器的功能解剖学
Cell. 2015 Jun 4;161(6):1374-87. doi: 10.1016/j.cell.2015.05.010. Epub 2015 May 28.